Author - Franklin Jay

Introduction Ocugen, Inc. (NASDAQ: OCGN) is a clinical-stage biotech focused on gene therapies for...

Opening Recap Market Pulse: Equities drifted around break-even as headline risk on fiscal plans and...

Senti Biosciences (NASDAQ: SNTI) is a clinical-stage biotechnology company pioneering gene-circuit...

Market Pulse: Markets edged up as AI enthusiasm collided with stubborn trade headwinds. HCL’s $3B...

Company Overview & Recent Developments Travere Therapeutics (NASDAQ: TVTX) is a commercial-stage...

Good morning, happy Tuesday—January 13, 2026. Crank up the coffee: here’s your shot of caffeine and...

Introduction LB Pharmaceuticals (NASDAQ: LBRX) is a clinical-stage biopharmaceutical company...

Daily Financial Update Good morning! It’s Monday, January 12, 2026. Let’s cut through the noise and...

Overview: Wells Fargo recently maintained its neutral “Equal-Weight” stance on The Clorox Company...

Daily Financial Update Opening Recap Market Pulse: AI ambitions are rippling across chip and...